+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 16 Actively Recruiting clinical trials

C

Actively Recruiting

Researchers are evaluating the effectiveness of different palatal dressing materials for healing wounds after free gingival graft surgery. This randomized controlled trial will include 30 healthy patients with mucogingival defects who need free gingival grafts. The study aims to find out which dressing provides better postoperative comfort and improves healing at the donor site. Participants will be randomly divided into three groups of 10. One group will receive a gelatin sponge with flowable composite as a control dressing. The second group will have hyaluronic acid gel applied and then covered with a gelatin sponge and flowable composite. The third group will receive active oxygen gel with the same covering materials. The grafts will be harvested using a standard surgical technique, and dressings will be applied to the donor site accordingly. Patients will be given pain medication and mouth rinse as standard postoperative care. Participants will be monitored through follow-up visits at 1, 2, and 4 weeks after surgery. Pain levels, analgesic use, wound healing progress using the Landry healing index, complete wound epithelialization via hydrogen peroxide test, wound size changes, and any complications will be assessed. These evaluations will help determine the healing quality and comfort associated with each dressing type over the four-week period.

Age: 18Years - 60YearsAll GendersPhase Not Applicable
1 location
S

Actively Recruiting

Researchers are evaluating whether giving magnesium sulphate to pregnant women at high risk of preterm birth can reduce the chance of cerebral palsy in their infants. This trial focuses on women between 32 and 35 weeks of pregnancy who are expected to deliver within 24 hours. The study also aims to assess the safety of magnesium sulphate for both mothers and newborns by comparing it to a placebo. Participants will be randomly assigned to receive either intravenous magnesium sulphate or a placebo. The magnesium sulphate is given as a 4 gram loading dose over 20 minutes, followed by a maintenance infusion of 1 gram per hour until delivery or for up to 24 hours. The placebo group receives an intravenous sodium chloride solution following the same schedule. Both groups will receive standard obstetric and neonatal care throughout the study. During the study, mothers will be monitored for side effects while receiving the infusion. Newborns will have routine assessments and cranial ultrasound screenings when needed. After discharge, infants will be followed up with neurodevelopmental evaluations to check for cerebral palsy. The main outcome measured is the combined rate of death or cerebral palsy at 6 months corrected age. The study will also track maternal side effects up to 48 hours after infusion and neonatal health up to 4 weeks after birth.

Age: 18Years - 45YearsFEMALEPhase 3
1 location
R

Actively Recruiting

This research evaluates augmentation techniques for the maxillary sinus floor in patients needing dental implants in areas with reduced bone height. It compares a new hydrogel-enhanced xenograft bone substitute with a graftless method that relies on the body forming bone after elevating the sinus membrane. The study aims to assess differences in tissue reaction, bone height, and bone quality between these two approaches. Participants undergo lateral maxillary sinus floor elevation either with the hydrogel-enhanced xenograft or with a graftless method involving stabilization of the elevated membrane using screws. This is done as a staged procedure, with implant placement planned after bone augmentation. The study includes two randomized groups one receiving the xenograft material and the other using membrane stabilization without graft material. During the study, participants will be monitored for postoperative swelling, pain, and tissue response. Radiographic imaging via CBCT will assess bone height and density before implant placement at 8 months. Bone samples will be collected for histological examination. Participant involvement includes follow-up visits to track healing and collect patient-reported symptoms, with the total study duration extending through the augmentation and implant preparation phases.

Age: 18Years - 65YearsAll GendersPhase 2Phase 3
3 locations
E

Actively Recruiting

Researchers are studying the combined effect of sensory-motor integration on individuals with postmenopausal polyneuropathy, a condition affecting nerve function and balance. The study aims to improve balance and reduce pain in women who have peripheral neuropathy after menopause, especially those with Type II Diabetes Mellitus and numbness in their limbs lasting more than four months. Participants will be randomly assigned to one of two groups. One group will receive sensory motor integration therapy, which includes tactile, thermal, and proprioceptive stimulation along with strengthening exercises and pelvic rocking training for six weeks. The other group will receive conventional exercises, involving free and gymnasium exercises for the upper and lower limbs plus 20 minutes of walking. During the six-week study, participants will be assessed for pain intensity and balance. Researchers will monitor changes in these measures to understand the effects of the different exercise programs. The study is sponsored by New Ismailia National University and includes women aged 45 to 55 years. Participants progress and safety will be monitored throughout the trial period.

Age: 45Years - 55YearsFEMALEPhase Not Applicable
2 locations
C

Actively Recruiting

Researchers are comparing two protocols for intravenous insulin infusion to improve blood sugar control in diabetic critically ill adults admitted to intensive care units at Suez Canal University SCU hospitals. The study aims to find out whether the SCU protocol is more effective than the National Health System NHS protocol used in the UK for managing blood glucose levels in these patients. This comparison will help determine the best way to control blood sugar in critically ill diabetic adults. Participants will be randomly assigned to one of two groups one group will follow the SCU insulin infusion protocol, while the other will follow the NHS protocol. Both groups will receive regular insulin through an intravenous infusion, with doses adjusted according to their assigned protocol and blood sugar levels. Nurses will prepare and monitor the insulin infusion carefully, stopping it if blood sugar falls below 80 mgdl. Potassium levels will be regularly checked and managed based on specific guidelines during the study. During the study, patients will have routine blood tests, including daily checks and more frequent potassium monitoring if needed. Researchers will collect information on their medical history, nutrition, mechanical ventilation duration, and any complications like diabetic ketoacidosis or hypoglycemia. Outcomes such as time to reach target blood glucose, ventilator-free days, ICU and hospital stay lengths, and mortality rates will be evaluated. The study will last up to 28 days, with ongoing assessments to monitor patients progress and safety.

Age: 19Years +All GendersPhase Not Applicable
1 location
S

Actively Recruiting

Researchers are evaluating the efficiency of direct 3D printed aligners in moving the crowns of upper and lower front teeth in adults with spacing issues during orthodontic space closure. This study focuses on comparing the actual tooth movements achieved with these aligners to the predicted movements planned before treatment. The trial will include adult patients aged 18 to 45 years with specific dental conditions, such as Angle Class I or mild Class II malocclusions and spacing between anterior teeth. Participants will receive direct 3D printed aligners designed after intraoral scans and 3D digital simulations of their teeth. Patients will be instructed to wear the aligners and to activate their shape memory by placing them in warm water before use. Aligners will be changed every 10 days throughout the treatment period, which lasts between 9 to 12 months. At the end of treatment, a new 3D scan will be taken to compare the actual tooth movements with the planned movements using digital superimposition techniques. During the study, patients will undergo intraoral scans before and after treatment, and 3D digital models will be created to measure crown movement in millimeters. These measurements will be analyzed statistically to determine the aligners effectiveness in achieving planned tooth movements. The study includes careful monitoring of dental health and malocclusion status, with no blinding or control group. The total duration of treatment and observation will be 9 to 12 months.

Age: 18Years - 45YearsAll GendersPhase Not Applicable
3 locations
S

Actively Recruiting

Healthy Volunteer

Researchers are evaluating how combining virtual reality with plyometric workouts affects abdominal obesity in adolescent females. This randomized clinical trial focuses on females aged 13 to 18 years who have abdominal obesity and a medical history of polycystic ovarian syndrome. The study aims to measure changes in waist circumference, waist-hip ratio, body mass index, and lung function over a 12-week period. A total of 100 adolescent females will be randomly assigned to two groups of 50 each. Study Group A will perform immersive virtual reality exercises combined with plyometric and abdominal workouts. Study Group B will engage in treadmill aerobic training combined with the same plyometric and abdominal exercises. Both groups will follow their respective programs consistently for three months. Participants will have key physical measurements and lung function tests taken before starting and after completing the treatment program. These include waist circumference, waist-hip ratio, body mass index, and pulmonary function assessed by electronic spirometry. The trial will monitor these outcomes to assess any improvements or changes related to the combined exercise approaches over the 12 weeks of study.

Age: 13Years - 18YearsFEMALEPhase Not Applicable
1 location
S

Actively Recruiting

This research focuses on adults aged 18 to 60 who need maxillary sinus floor augmentation for dental implants. The study compares two methods of lifting the Schneiderian membrane in the maxillary sinus during the sinus lift procedure. It aims to evaluate the clinical, radiographic, and histologic outcomes of using titanium mesh versus stainless steel screws or pins to maintain the elevated membrane and stabilize the blood clot. Participants are divided into two groups Group I, where the membrane is elevated using titanium mesh fixed with bone screws, and Group II, where stainless steel screws or pins are used bucco-palatally. In both groups, platelet rich fibrin PRF is placed at the site of the elevated membrane. The study involves a randomized assignment to these groups and includes a single-blind design. During the study, researchers will assess bone quality through histological evaluation and measure radiographic bone gain six months after the maxillary sinus lift procedure. Participants will undergo clinical and radiographic evaluations to monitor the outcomes. The total participation period includes follow-up assessments at six months to understand bone regeneration and implant support potential.

Age: 18Years - 60YearsAll GendersPhase Not Applicable
1 location
E

Actively Recruiting

Healthy Volunteer

This research aims to evaluate how virtual reality combined with diaphragmatic release, an active relaxation technique, affects painful menstruation in adolescent females. The study focuses on non-drug methods to manage menstrual pain and explores the potential benefits of immersive virtual reality technology, which has shown promise in reducing pain and anxiety in various minor medical procedures. Participants will be randomly assigned to one of two groups. One group will use virtual reality combined with diaphragmatic breathing, while the other will receive cold laser treatment combined with the same breathing technique. Both treatments will be applied for 10 consecutive days each month over a period of three months. During the study, participants will be monitored for pain intensity over these 10-day periods across three months. They will also complete the Menstrual Distress Questionnaire to assess menstrual symptoms. The study includes follow-ups to track pain levels and menstrual distress to better understand the impact of these non-pharmacological interventions on painful menstruation.

Age: 13Years - 20YearsFEMALEPhase Not Applicable
2 locations
S

Actively Recruiting

Researchers are evaluating whether intranasal dexmedetomidine can help control blood pressure in elderly patients with controlled hypertension undergoing cataract surgery. This phase 3, randomized, double-blind clinical trial aims to reduce fluctuations in mean arterial blood pressure MAP during the perioperative period. The study also assesses secondary outcomes such as surgery cancellation rates and satisfaction levels among patients, anesthesiologists, and surgeons using sedation scales. Participants will be randomly assigned to receive either intranasal dexmedetomidine at a dose of 1 mcgkg ideal body weight or a placebo of normal saline. The medication or placebo will be administered 30 minutes before surgery using a mucosal atomization device, delivering 0.5 mL into each nostril while the patient is semi-recumbent. Local anesthesia will be given through a peribulbar block with lidocaine and bupivacaine by an experienced anesthesiologist under aseptic conditions. During the study, researchers will monitor mean arterial blood pressure, heart rate, and oxygen saturation from before surgery until two hours afterward. They will also record surgery cancellation rates, sedation scores, and satisfaction assessments from patients, anesthesiologists, and surgeons. Surgical duration and hospital stay will be documented to evaluate the interventions effects comprehensively. The total participation duration spans from preoperative baseline through the immediate postoperative period.

Age: 65Years +All GendersPhase 3
1 location

1-10 of 16

1